These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33567548)

  • 1. Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3): A Novel Marker for Lymphoma Development among Patients with Young Onset Sjogren's Syndrome.
    Argyriou E; Nezos A; Roussos P; Venetsanopoulou A; Voulgarelis M; Boki K; Tzioufas AG; Moutsopoulos HM; Mavragani CP
    J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33567548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein-Associated Phospholipase A2: A Novel Contributor in Sjögren's Syndrome-Related Lymphoma?
    Nezos A; Skarlis C; Psarrou A; Markakis K; Garantziotis P; Papanikolaou A; Gravani F; Voulgarelis M; Tzioufas AG; Koutsilieris M; Moutsopoulos HM; Kotsifaki E; Mavragani CP
    Front Immunol; 2021; 12():683623. PubMed ID: 34220834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNFAIP3 F127C Coding Variation in Greek Primary Sjogren's Syndrome Patients.
    Nezos A; Gkioka E; Koutsilieris M; Voulgarelis M; Tzioufas AG; Mavragani CP
    J Immunol Res; 2018; 2018():6923213. PubMed ID: 30662920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjögren's syndrome.
    Du Y; Su Y; He J; Yang Y; Shi Y; Cui Y; Luo C; Wu X; Liu X; Hu F; Ma X; Zheng L; Zhang J; Zuo X; Sheng Y; Wu L; Zhang X; Guo J; Li Z
    Ann Rheum Dis; 2015 Nov; 74(11):2070-5. PubMed ID: 24906639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the Leukocyte Immunoglobulin-like Receptor A3 Gene With Neutrophil Activation and Disease Susceptibility in Adult-Onset Still's Disease.
    Wang M; Liu M; Jia J; Shi H; Teng J; Liu H; Sun Y; Cheng X; Ye J; Su Y; Chi H; Liu T; Wang Z; Wan L; Meng J; Ma Y; Yang C; Hu Q
    Arthritis Rheumatol; 2021 Jun; 73(6):1033-1043. PubMed ID: 33381895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low miR200b-5p levels in minor salivary glands: a novel molecular marker predicting lymphoma development in patients with Sjögren's syndrome.
    Kapsogeorgou EK; Papageorgiou A; Protogerou AD; Voulgarelis M; Tzioufas AG
    Ann Rheum Dis; 2018 Aug; 77(8):1200-1207. PubMed ID: 29779010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3) Is Increased in Patients with Multiple Sclerosis and Is a Strong Independent Indicator of Disease Severity; 6.7kbp LILRA3 Gene Deletion Is Not Associated with Diseases Susceptibility.
    An H; Lim C; Guillemin GJ; Vollmer-Conna U; Rawlinson W; Bryant K; Tedla N
    PLoS One; 2016; 11(2):e0149200. PubMed ID: 26871720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome.
    Nezos A; Papageorgiou A; Fragoulis G; Ioakeimidis D; Koutsilieris M; Tzioufas AG; Moutsopoulos HM; Voulgarelis M; Mavragani CP
    J Autoimmun; 2014 Jun; 51():89-98. PubMed ID: 23845207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of performance of the 2016 ACR-EULAR classification criteria for primary Sjögren's syndrome with other sets of criteria in Japanese patients.
    Tsuboi H; Hagiwara S; Asashima H; Takahashi H; Hirota T; Noma H; Umehara H; Kawakami A; Nakamura H; Sano H; Tsubota K; Ogawa Y; Takamura E; Saito I; Inoue H; Nakamura S; Moriyama M; Takeuchi T; Tanaka Y; Hirata S; Mimori T; Matsumoto I; Sumida T
    Ann Rheum Dis; 2017 Dec; 76(12):1980-1985. PubMed ID: 28330998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of the 2016 ACR-EULAR and the 2002 AECG classification criteria for Sjögren's syndrome: Findings from the NIH cohort.
    Billings M; Amin Hadavand M; Alevizos I
    Oral Dis; 2018 Mar; 24(1-2):184-190. PubMed ID: 29480635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of dry eye in patients with pre-existing Sjögren's syndrome according to the revised 2016 ACR-EULAR classification criteria.
    Yoon HJ; Choi W; Yang JM; Ji YS; Lee SS; Yoon KC
    Medicine (Baltimore); 2019 Mar; 98(9):e14641. PubMed ID: 30817584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LILRA3 deletion is a genetic risk factor of HIV infection.
    Ahrenstorf G; Low HZ; Kniesch K; Ordonez D; Meyer-Olson D; Ahmad F; Kücherer C; Gunsenheimer-Bartmeyer B; Stoll M; Matthias T; Schmidt RE; Witte T
    AIDS; 2017 Jan; 31(1):25-34. PubMed ID: 27755104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A BAFF receptor His159Tyr mutation in Sjögren's syndrome-related lymphoproliferation.
    Papageorgiou A; Mavragani CP; Nezos A; Zintzaras E; Quartuccio L; De Vita S; Koutsilieris M; Tzioufas AG; Moutsopoulos HM; Voulgarelis M
    Arthritis Rheumatol; 2015 Oct; 67(10):2732-41. PubMed ID: 26097183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte immunoglobulin-like receptor A3 gene deletion in five Chinese populations and protective association with nasopharyngeal carcinoma.
    Tian W; Li LX; Cheng W; Jin HK; Zhang SS
    Int J Immunogenet; 2024 Feb; 51(1):32-38. PubMed ID: 38015196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble LILRA3, a potential natural antiinflammatory protein, is increased in patients with rheumatoid arthritis and is tightly regulated by interleukin 10, tumor necrosis factor-alpha, and interferon-gamma.
    An H; Chandra V; Piraino B; Borges L; Geczy C; McNeil HP; Bryant K; Tedla N
    J Rheumatol; 2010 Aug; 37(8):1596-606. PubMed ID: 20595277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. +3179G/A Insulin-Like Growth Factor-1 Receptor Polymorphism: A Novel Susceptibility Contributor in Anti-Ro/SSA Positive Patients with Sjögren's Syndrome: Potential Clinical and Pathogenetic Implications.
    Skarlis C; Marketos N; Nezos A; Papanikolaou A; Voulgarelis M; Koutsilieris M; Moutsopoulos HM; Mavragani CP
    J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic contributors and soluble mediators in prediction of autoimmune comorbidity.
    Nezos A; Evangelopoulos ME; Mavragani CP
    J Autoimmun; 2019 Nov; 104():102317. PubMed ID: 31444033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis.
    Nezos A; Gravani F; Tassidou A; Kapsogeorgou EK; Voulgarelis M; Koutsilieris M; Crow MK; Mavragani CP
    J Autoimmun; 2015 Sep; 63():47-58. PubMed ID: 26183766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Bruton's Tyrosine Kinase Gene Overexpression and Risk of Lymphoma in Primary Sjögren's Syndrome.
    Duret PM; Schleiss C; Kawka L; Meyer N; Ye T; Saraux A; Devauchelle-Pensec V; Seror R; Larroche C; Perdriger A; Sibilia J; Vallat L; Fornecker LM; Nocturne G; Mariette X; Gottenberg JE
    Arthritis Rheumatol; 2023 Oct; 75(10):1798-1811. PubMed ID: 37115807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European League Against Rheumatism Sjögren's Syndrome Disease Activity Index and European League Against Rheumatism Sjögren's Syndrome Patient-Reported Index: a complete picture of primary Sjögren's syndrome patients.
    Seror R; Gottenberg JE; Devauchelle-Pensec V; Dubost JJ; Le Guern V; Hayem G; Fauchais AL; Goeb V; Hachulla E; Hatron PY; Larroche C; Morel J; Pedriger A; Puechal X; Rist S; Saraux A; Sene D; Sibilia J; Vittecoq O; Zarnitsky C; Labetoulle M; Ravaud P; Mariette X
    Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1358-64. PubMed ID: 23436737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.